Elucidating the specific pharmacological mechanism of motion (MOA) of Obviously taking place compounds is usually challenging. Even though Tarselli et al. (60) designed the first de novo synthetic pathway to conolidine and showcased that this In a natural way transpiring compound efficiently suppres